Moderna defended the use of its Covid vaccine, saying the protection it offers against severe disease, hospitalization and death outweighs the risk of myocarditis. Reported cases of the rare heart inflammation in men under 30 are relatively higher after Moderna’s vaccine compared with Pfizer’s.